ArticleScience translational medicine2021

Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.

Christopher S Garris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.